Topical Treatment Strategies for Non-Melanoma Skin Cancer and Precursor Lesions

The ability to manage non-melanoma skin cancers and pre-malignant lesions with topical pharmacologic agents is highly compelling. This article examines currently available products and discusses their emerging roles and limitations. These include fluorouracil, diclofenac sodium, imiquimod, and photodynamic therapy.

Semin Cutan Med Surg 23:174-183 © 2004 Elsevier Inc. All rights reserved.

The ability to manage non-melanoma skin cancers and pre-malignant lesions with topical pharmacologic agents is highly compelling.

Purchase this article:

PURCHASE FOR $25

For unlimited access to all issues and articles:

SUBSCRIBE NOW LOG IN TO ACCOUNT

If you do not subscribe to Seminars in Cutaneous Medicine and Surgery, you may purchase instant access for your personal use. Terms and conditions will apply (see Copyright & Terms of Use). If you need assistance, contact Susan Hite ([email protected]).